Innoviva (INVA) Net Cash Flow (QoQ) (2010 - 2025)
Innoviva (INVA) Net Cash Flow (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 118.70% |
| Jun 30, 2025 | 455.30% |
| Sep 30, 2024 | 73.67% |
| Jun 30, 2024 | 354.99% |
| Sep 30, 2023 | -483.26% |
| Jun 30, 2023 | 119.71% |
| Sep 30, 2022 | 48.71% |
| Jun 30, 2022 | 337.11% |
| Sep 30, 2021 | 53.52% |
| Jun 30, 2021 | -758.26% |
| Mar 31, 2021 | 115.64% |
| Dec 31, 2020 | -452.34% |
| Sep 30, 2020 | 7.98% |
| Jun 30, 2020 | -17.21% |
| Mar 31, 2020 | -29.73% |
| Dec 31, 2019 | 239.26% |
| Sep 30, 2019 | -59.64% |
| Jun 30, 2019 | 2,709.11% |
| Mar 31, 2019 | -80.19% |
| Dec 31, 2018 | 135.75% |